Net revenues of $171.2 million for the three months ended March 31, 2026 GAAP net income of $6.4 million, or $0.14 per share, ... · ACCESS Newswire · Amphastar Pharmaceuticals, Inc. Amphastar ...
The FDA has advised consumers not to use albuterol sulfate inhalation solution, 0.083%, and ipratropium bromide inhalation solutions, 0.02%, unit-dose vials, purchased after September 8, 2009 and ...
Albuterol or salbutamol and Ipratropium combination is prescribed to prevent wheezing, difficulty in breathing, chest tightness, and coughing in chronic obstructive pulmonary disease (COPD) such as ...
Discover comprehensive details about Albuterol and Ipratropium, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...
RIDGEFIELD, Conn., April 13 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" ...
ATLANTA, Georgia — Patients with chronic obstructive pulmonary disease (COPD) experience few adverse events and discontinuations when treated with an ipratropium plus albuterol inhalation spray (CVT-R ...
Lupin is releasing Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, which are the generic of Boehringer Ingelheim’s Atrovent Nasal Spray, 0.03% and 0.06%. Ipratropium Bromide Nasal ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Atrovent UDV? Atrovent Unit Dose Vial (UDV) contains ...
The GINA 2026 update covers primary care management of asthma exacerbations, fatality risk factors, biologic selection, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results